TYSEDMUS Study
TYSEDMUS is a multicentric cohort study of French MS patients treated and non treated with Tysabri® (Natalizumab).
An English synopsis of the study can be downloaded below:
Download TYSEDMUS study synopsis
Further information will be found in the French-language section of this site:
TYSEDMUS (in French)